+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Left atrial appendage occlusion with the WATCHMAN™ for stroke prevention in atrial fibrillation



Left atrial appendage occlusion with the WATCHMAN™ for stroke prevention in atrial fibrillation



Reviews in Cardiovascular Medicine 15(2): 142-151



Atrial fibrillation (AF) is a major cause of stroke and systemic embolism. Although warfarin and the novel oral anticoagulants reduce thromboembolic risk, they are associated with an ongoing bleeding hazard, in addition to other limitations that deter their use. The left atrial appendage (LAA) appears to be the primary source of thrombus in AF; therefore, LAA closure represents a mechanical strategy for stroke prevention in these patients. The WATCHMAN™ LAA closure device (Boston Scientific, Natick, MA) is a nitinol-framed occluder that is implanted percutaneously under echocardiographic and fluoroscopic guidance. Data from two randomized clinical trials support the clinical efficacy of transcatheter LAA occlusion with the WATCHMAN and demonstrate that procedural safety has improved significantly since initial experience. This article summarizes the rationale, procedural technique, safety, and clinical efficacy of the WATCHMAN device in patients with AF at high risk for thromboembolic events.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 054097138

Download citation: RISBibTeXText

PMID: 25051131


Related references

The clinical impact of incomplete left atrial appendage closure with the Watchman Device in patients with atrial fibrillation: a PROTECT AF (Percutaneous Closure of the Left Atrial Appendage Versus Warfarin Therapy for Prevention of Stroke in Patients With Atrial Fibrillation) substudy. Journal of the American College of Cardiology 59(10): 923-929, 2012

Percutaneous left atrial appendage closure for stroke prophylaxis in patients with atrial fibrillation: 2.3-Year Follow-up of the PROTECT AF (Watchman Left Atrial Appendage System for Embolic Protection in Patients with Atrial Fibrillation) Trial. Circulation 127(6): 720-729, 2013

Novel stroke risk reduction in atrial fibrillation: left atrial appendage occlusion with a focus on the Watchman closure device. Vascular Health and Risk Management 13: 81-90, 2017

Percutaneous left atrial appendage occlusion with a Watchman device following recurrent stroke on warfarin and rivaroxaban in patient with paroxysmal atrial fibrillation. Heart Lung and Circulation 23(2): 171-173, 2014

Initial worldwide experience with the WATCHMAN left atrial appendage system for stroke prevention in atrial fibrillation. Journal of the American College of Cardiology 49(13): 1490-1495, 2007

WATCHMAN left atrial appendage system for stroke prevention in atrial fibrillation: a percutaneous-device delivery approach. Future Cardiology 3(5): 507-509, 2007

Post-Approval U.S. Experience With Left Atrial Appendage Closure for Stroke Prevention in Atrial Fibrillation. Journal of the American College of Cardiology 69(3): 253-261, 2017

Initial experience with the WATCHMAN™ left atrial appendage system for stroke prevention in atrial fibrillation: A single-centre registry. Archives of Cardiovascular Diseases 109(12): 689-695, 2016

Primary and Secondary Stroke Prevention Using Left Atrial Appendage Closure with Watchman Devices in Atrial Fibrillation Patients: A Single Center Experience from Mainland China. Pacing and Clinical Electrophysiology 40(6): 607-614, 2017

Efficacy and Safety of the WATCHMAN Left Atrial Appendage System for Stroke Prevention in Chinese Patients with Nonvalvular Atrial Fibrillation: A Single-center, Prospective, Observational Study. Chinese Medical Journal 130(4): 434-438, 2017

Left atrial appendage occlusion using LAmbre Amulet and Watchman in atrial fibrillation. Journal of Cardiology 73(4): 299-306, 2019

Is left atrial appendage occlusion useful for prevention of stroke or embolism in atrial fibrillation?. Zeitschrift fuer Kardiologie 91(5): 376-379, Mai, 2002

To occlude or not? Left atrial appendage occlusion for stroke prevention in atrial fibrillation. Heart 103(2): 93-95, 2017

Left atrial appendage occlusion for stroke prevention in patients with atrial fibrillation. Clinical Cardiology 40(10): 825-831, 2017

Left Atrial Appendage Occlusion for Stroke Prevention in Patients with Atrial Fibrillation. Interventional Cardiology Clinics 7(2): Xiii-Xxiv, 2018